"Saving lives": Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria.
Soc Sci Med
; 153: 193-200, 2016 Mar.
Article
en En
| MEDLINE
| ID: mdl-26921834
ABSTRACT
Vaccination against the sexually transmitted Human Papilloma Virus (HPV), a necessary agent for the development of cervical cancer, has triggered much debate. In Austria, HPV policy turned from "lagging behind" in 2008 into "Europe's frontrunner" by 2013. Drawing on qualitative research, the article shows how the vaccine was transformed and made "good enough" over the course of five years. By means of tinkering and shifting storylines, policy officials and experts disassociated the vaccine from gender, vaccine manufacturers, and youth sexuality. Ultimately, the HPV vaccine functioned to strengthen the national immunization program. To this end, preventing an effective problematization of the extant screening program was essential.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Papillomavirus
/
Vacunas contra Papillomavirus
/
Política de Salud
Tipo de estudio:
Diagnostic_studies
/
Qualitative_research
/
Screening_studies
Límite:
Child
/
Female
/
Humans
/
Male
País/Región como asunto:
Europa
Idioma:
En
Revista:
Soc Sci Med
Año:
2016
Tipo del documento:
Article